Use of benzodiazepines in the aging population: Do the benefits outweigh the risks?

Principles and Practice of Geriatric Sleep Medicine

Volumn , Issue , 2009, Pages 362-370

  Lader, Malcolm H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80455165974     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511770661.037     Document Type: Chapter

References (40)

1. Glass J, Lanctot KL, Herrmann, N, et al. Sedative hypnotics in older people with insomnia; meta-analysis of risks and benefits. BMJ 2005; 331: 1169-73.
2. Ancoli-Israel S. Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. J Clin Psychiatry 2005; 66 (Suppl. 9): 24-30.
3. Byrne J. Insomnia in older people: current approaches to treatment. Prescriber 2006;19 June: 54-6.
4. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depression Anxiety 2003; 18: 163-76.
5. Castleden CM, George CF, Marcer D, Hallett C. Increased sensitivity to nitrazepam in old age. BMJ 1977; 1: 10-2.
6. Kamel NS, Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006; 119: 463-9.
7. National Institutes of Health State-of-the-Art Conference Statement. Final Statement 18 August, 2005. Available at http://consensus. nih. gov/2005/2005in somniaS0S026html. htm. Accessed 24 September, 2007.
8. Lachnit K, Proszolowski E, Rieder L. Midazolam in the treatment of sleep disorders in geriatric patients. Br J Clin Pharmacol 1983; 16 (Suppl.): 173-75.
9. Mamelak M, Csima A, Buck L, Price V. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharm 1989; 9: 260-7.
10. Richards HH, Valle-Jones CJ. A double-blind comparison of two lormetazepam doses in elderly insomniacs. Curr Med Res Opin 1988; 11: 48-55.
11. Bayer A, Pathy MSJ. Clinical and psychometric evaluation of 2 doses of loprazolam and placebo in geriatric patients. Curr Med Res Opin 1986; 10: 17-24.
12. Caldwell JR. Short-term quazepam treatment of insomnia in geriatric patients. Pharmatherapeutica 1982; 3: 278-82.
13. Roth T, Roehrs TA, Ksohorek GL, et al. Hypnotic effects of low doses of quazepam in older insomniacs. J Clin Psychopharmacol 1997; 17: 401-6.
14. Fairweather DB, Kerr JS, Hindmarch I. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 1992; 43: 597-601.
15. Najib J. Eszopiclone, a nonbenzodiazepine sedativehypnotic agent for the treatment of transient and chronic insomnia. Clin Ther 2006; 28: 491-516.
16. Erman M, Rosenberg R, Caron Y. Polysomnographic and patient-reported evaluation of the efficacy and safety of eszopiclone in elderly subjects with chronic insomnia. Sleep 2004; 27 (Suppl. 6): 257-8.
17. Scharf M, Erman M, Rosenberg R, et al. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep 2005; 28: 720-7.
18. Hedner J, Yaeche R, Emilien G, Farr I, Salinas E. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry 2000; 15: 704-12.
19. Overstall P, Oldman PN. A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing 1987; 16: 45-51.
20. Cook PJ, Huggett A, Grahame-Pole R, et al. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. BMJ 1983; 286: 100-2.
21. Murphy P, Hindmarch I, Hyland CM. Aspects of short-term use of two benzodiazepine hypnotics in the elderly. Age Ageing 1982; 11: 222-8.
22. Reeves R. Comparison of triazolam, flurazepam, and placebo as hypnotics in geriatric patients with insomnia. J Clin Pharmacol 1977; 17: 319-23.
23. Bayer AJ, Pathy MS, Ankier SI. An evaluation of the short-term hypnotic efficacy of loprazolam in comparison with nitrazepam in elderly patients. Pharmatherapeutica 1983; 3: 468-74.
24. Dehlin O, Bjornson J. Triazolam as a hypnotic for geriatric patients. Act Psychiatr Scand 1983; 67: 290-6.
25. Mouret J, Ruel D, Maillard F, Bianchi M. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. Int Clin Psychopharmacol 1990; 5 (Suppl. 2): 47-55.
26. Dehlin O, Rubin B, Rundgren A. Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects. Curr Med Res Opin 1995; 13: 317-24.
27. Elie R, Frenay M, Le Morvan P, Bourgouin J. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. Int Clin Psychopharmacol 1990; 5 (Suppl. 2): 39-46.
28. Hindmarch I, Legangeux E, Neil S, et al. A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. Br J Clin Pharmacol 2006; 62: 538-45.
29. Pathy MSJ, Bayer AJ, Stoker MJ. A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. Acta Psychiatrica Scand 1986; 73 (Suppl. 329): 99-103.
30. Bayer AJ, Bayer EM, Pathy MSJ, Stoker MJ. A doubleblind study of chlormethiazole and triazolam as hypnotics in the elderly. Acta Psychiatrica Scand 1986; 73 (Suppl. 329): 104-11.
31. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia. JAMA 2006; 295: 2851-8.
32. Morin C, Colecchi C, Stone J, Sood R, Brink D. Behavioural and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281: 991-9.
33. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18: 297-328.
34. Vogel G. Clinical uses and advantages of low doses of benzodiazepine hypnotics. J Clin Psychiatry 1992; 53 (suppl): 19-22.
35. Soldatos CR, Dikeos DG, Whitehead A. Tolerance and rebound with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. J Clin Psychopharmacol 1999; 14: 287-303.
36. Lader M. Withdrawal reactions aft er stopping hypnotics in patients with insomnia. CNS Drugs 1998; 10: 425-40.
37. Lader M. Rebound and withdrawal with benzodiazepine and non-benzodiazepine hypnotic medication. In Pandi-Perumal SR, Monti JM, eds Clinical Pharmacology of Sleep. Basel: Birkhauser; 2006: pp. 225-5.
38. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006; 4: 168-92.
39. Dolder C, Nelson M, McKinsey J. Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs 2007; 21: 389-405.
40. Anonymous. What's wrong with prescribing hypnotics? Drug Ther Bull 2004; 42: 89-93.